Skip to main content

Coronavirus update: 185,067 cases, 7,330 deaths, COVID-19 clinical trials begin in the U.S.

As COVID-19 case counts and deaths continue to rise and the stock market has struggled to regain its footing, one bright spot are the drugmakers and diagnostics companies moving forward with plans to develop tests, treatments, and vaccines for the novel coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.